Mycosis fungoides and pregnancy.

Castelo-Branco, Camil; Torné, Aureli; Cararach, Vicenç; Iglesias, Xavier

doi:10.3892/or.8.1.197

Cited by 12 publications

(9 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most common NHL subtypes seen in pregnancy are of an aggressive histology, such as diffuse large B-cell lymphoma (DLBCL). However, other histological variants have also been reported, including Burkitt lymphoma [55][56][57][58][59][60][61][62][63][64][65], follicular lymphoma [59,66], MALT lymphoma [67,68], mycosis fungoides [69,70], anaplastic large cell lymphoma [71,72], hepatosplenic T-cell lymphoma [73], NK/T-cell lymphoma [74], adult T-cell leukemia/lymphoma [75], and subcutaneous panniculitis-like T-cell lymphoma [76,77]. Presenting symptoms of NHL can be unusual during pregnancy leading to delays in diagnosis [78].…”

Section: Non-hodgkin Lymphomamentioning

confidence: 99%

Management of hematological malignancies during pregnancy

et al. 2009

View full text Add to dashboard Cite

The management of hematological malignancies during pregnancy is a challenging endeavor, which not only requires technical skills and knowledge by the clinicians but also requires sound clinical judgment and compassion, keeping in mind the patient and family preferences and, ultimately, the wellbeing of the neonate. The incidence of hematological malignancies during pregnancy is rare, ranging from 1 in 1,000 to 1 in 10,000 deliveries, impeding the design and execution of large prospective studies. The purpose of this review is to evaluate the limited existing data and make useful suggestions in the management of acute and chronic leukemias, Hodgkin and non‐Hodgkin lymphomas, plasma cell myeloma, and other hematological malignancies, such as myelodysplastic syndromes and hairy cell leukemia, during pregnancy. Am. J. Hematol. 2009. © 2009 Wiley‐Liss, Inc.

show abstract

Section: Non-hodgkin Lymphomamentioning

confidence: 99%

Management of hematological malignancies during pregnancy

et al. 2009

View full text Add to dashboard Cite

show abstract

“…All these situations require a multidisciplinary approach (Aviles et al, 1991;Maloisel et al, 1996;Peleg & Ben-Ami, 1998). Hemato-logical malignancies associated with pregnancy, such as Hodgkin's disease (HD), acute leukemia, non-Hodgkin's lymphoma (NHL), myelodysplastic syndrome (MDS) and, less frequently, essential thrombocythemia (ET), chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), and mycosis fungoides, have been reported (Falconer et al, 1987;Caligiuri & Mayer, 1989;Aviles et al, 1990;Lishner et al, 1992;Cinkotai et al, 1994;Castelo-Branco et al, 2001;Steensma & Tefferi, 2001;Gurman, 2002;Ikeda & Masuzaki, 2002). Treatment for most of these diseases includes intensive chemotherapeutic regimens.…”

Section: Introductionmentioning

confidence: 99%

Hematological malignancy and pregnancy: a single-institution experience of 21 cases

et al. 2006

View full text Add to dashboard Cite

The incidence of hematological malignancies during pregnancy is low, and treatment in this setting is problematic. This study observed 21 pregnancies in 18 patients with hematological malignancies. Patients' ages were between 19 and 43 (median 25) years. Two pregnancies ended with spontaneous abortion, one pregnancy ended with in utero death, three therapeutic abortions were carried out, and 15 infants were born alive but three of them died later. The median birth weight was 2.47 kg. Twelve babies survived to a median age of 36 (range 4-117) months. Eight babies were exposed to chemotherapy during the in utero period. One baby was exposed to chemotherapy during all the trimesters and was born prematurely and later died because of intracranial bleeding. Four babies were exposed to chemotherapy during the first trimester, one of them had low birth weight and floating thumb malformation, two of them had only low birth weight, and one was born healthy, but died at 3 months of age as a result of severe gastroenteritis. Two babies were exposed to chemotherapy during the second and third trimesters; one of them had low birth weight, and the other pregnancy ended in in utero death. One infant was exposed to chemotherapy during the third trimester and was born at term, but died because of pulmonary hemorrhage. We concluded that chemotherapy during all trimesters of pregnancy carries a significant risk for an unfavorable outcome.

show abstract

“…2 Of these, mycosis fungoides (MF) is very uncommon, with only rare case reports in the literature. 3,4 Treatment options in a pregnant patient diagnosed with a malignancy pose unique ethical issues because of competing obligations between mother and fetus. 5 The patient's consideration and ultimate decision on whether or not to continue or terminate the pregnancy is complicated because of these competing interests.…”

Section: Discussionmentioning

confidence: 99%